Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Compass Therapeutics, Inc. COMMON STOCK (CMPX).
- Disclosed ownership: 11%.
- Date of event: 09 Apr 2024.
ORBIMED ADVISORS LLC - 09 Apr 2024 SCHEDULE 13D/A Report for Compass Therapeutics, Inc. COMMON STOCK (CMPX)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- CMPX
- Shares outstanding
- 138,363,582 shares
- Disclosed Ownership
- 15,219,994 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13D/A
- Filing time
- 11 Apr 2025, 19:21:13 UTC
- Date of event
- 09 Apr 2024
- Next filing
- 15 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 11% ownership in Compass Therapeutics, Inc. COMMON STOCK (CMPX) on 09 Apr 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Apr 2025, 19:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11% | 15,219,994 | 0 | 15,219,994 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| ORBIMED CAPITAL GP V LLC | 11% | 15,219,994 | 0 | 15,219,994 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001615374 |
| OrbiMed Genesis GP LLC | 0% | 0 | 0 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001808744 |
| ORBIMED CAPITAL LLC | 0% | 0 | 0 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001157524 |